These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9734214)

  • 1. [Clinical and molecular genetics of hypertrophic cardiomyopathy].
    Sepp R; Csanády M
    Orv Hetil; 1998 Aug; 139(33):1965-71. PubMed ID: 9734214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy.
    Capek P; Brdicka R
    Cas Lek Cesk; 2006; 145(2):93-6; discussion 96-7. PubMed ID: 16521396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
    Domal-Kwiatkowska D; Smolik S; Mazurek U; Moric E; Polońska J; Nowalany-Kozielska E; Glanowska G; Wodniecki J; Szarek J; Wilczewski P; Kozakiewicz K; Tendera M; Wilczok T
    Wiad Lek; 2000; 53(1-2):4-21. PubMed ID: 10806915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
    Marian AJ; Roberts R
    Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the flanking nucleotide sequences of sarcomeric hypertrophic cardiomyopathy substitution mutations.
    Meurs KM; Mealey KL
    Mutat Res; 2008 Jul; 642(1-2):86-9. PubMed ID: 18539302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyopathy: molecular and immunological aspects (review).
    Takeda N
    Int J Mol Med; 2003 Jan; 11(1):13-6. PubMed ID: 12469210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences.
    Doolan A; Tebo M; Ingles J; Nguyen L; Tsoutsman T; Lam L; Chiu C; Chung J; Weintraub RG; Semsarian C
    J Mol Cell Cardiol; 2005 Feb; 38(2):387-93. PubMed ID: 15698845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?
    Brito D; Madeira H
    Rev Port Cardiol; 2005 Sep; 24(9):1137-46. PubMed ID: 16335287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetical heterogeneity of familial hypertrophic cardiomyopathy.
    Hengstenberg C; Carrier L; Schwartz K; Maisch B
    Herz; 1994 Apr; 19(2):84-90. PubMed ID: 8194836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease.
    Charron P; Komajda M
    Expert Rev Mol Diagn; 2006 Jan; 6(1):65-78. PubMed ID: 16359268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
    Sorajja P; Elliott PM; McKenna WJ
    Europace; 2000 Jan; 2(1):4-14. PubMed ID: 11225594
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular genetics of cardiomyopathies.
    Marian AJ; Roberts R
    Herz; 1993 Aug; 18(4):230-7. PubMed ID: 8375803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypertrophic cardiomiopathy: molecular basis and genotype-phenotype correlations.
    Cuda G; Lamberti A; Perrotti N; Perticone F; Mattioli PL
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II21-31. PubMed ID: 9835779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C].
    García-Pavía P; Segovia J; Molano J; Mora R; Kontny F; Erik Berge K; Leren TP; Alonso-Pulpón L
    Rev Esp Cardiol; 2007 Mar; 60(3):311-4. PubMed ID: 17394878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.